Journal article · 2026 · Open access
Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response
IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81 · Published 8 August 2026 · DOI 10.18231/j.ijcaap.18440.1784180812
In brief
“Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response” is a 2026 journal article by Gauri Vijay Londhe and 2 co-authors, published in IP International Journal of Comprehensive and Advanced Pharmacology. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at IP International Journal of Comprehensive and Advanced Pharmacology.
- Citations
- 0
- References
- 63
- Authors
- 3
Abstract
Variability between different people when responding to drugs is a very large problem in clinical therapeutics, and can lead to treatment failures, adverse drug reactions, or under-dosing. Pharmacogenetics involves the study of the variation of one gene which affects a person's response to a single drug, while pharmacogenomics focuses on multiple genes and genome-wide variation on drug efficacy, safety, absorption, distribution, metabolism and excretion. These disciplines collectively serve as the building blocks of precision medicine and will allow for tailoring of drug therapy based on a person's genetic make-up. This review aims to offer a broad overview of the genetic determinants of drug variability, especially polymorphisms in drug metabolizing enzymes, such as the cytochrome P450 (CYP450) family, drug transporters and therapeutic target receptors. Pharmacogenomic markers of relevance to clinical practice are covered in the fields of oncology, cardiovascular diseases, psychiatry and pain management, with examples of how these markers can be incorporated into evidence-based guidelines with the help of organizations like the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the U.S. Food and Drug Administration (FDA). The review also provides space for some of the emerging new approaches for high throughput genotyping, next generation sequencing, and bioinformatics, which have been driving the incorporation of pharmacogenomic information into clinical decision making. In addition, important factors that hinder routine clinical use of the test, such as economic issues, ethnic variation in allele frequency, ethical issues, data privacy, and the lack of health care professional training, are described and critically discussed. Future trends in the area of individualized therapy are discussed of emerging developments in pharmacometabolomics, microbiome research, artificial intelligence, predictive analytics and polygenetic risk scoring. In summary, this review provides a summary of the current understanding, highlights the existing gaps in the field, and highlights the increasing translational relevance of pharmacogenetics and pharmacogenomics to enhance therapeutic efficacy and progress personalized medicine.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Londhe, G. V., Phade, S., & Khuspe, K. P. (2026). Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response. IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812
MLA 9
Londhe, Gauri Vijay, et al. “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response.” IP International Journal of Comprehensive and Advanced Pharmacology, vol. 11, no. 2, 2026, pp. 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812.
Chicago
Londhe, Gauri Vijay, Swapnil Phade, and Kishori Pankaj Khuspe. 2026. “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response.” IP International Journal of Comprehensive and Advanced Pharmacology 11 (2): 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812.
Harvard
Londhe, G. V., Phade, S. and Khuspe, K. P. (2026) ‘Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response’, IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), pp. 71–81. doi:10.18231/j.ijcaap.18440.1784180812.
IEEE
G. V. Londhe, S. Phade, and K. P. Khuspe, “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response,” IP International Journal of Comprehensive and Advanced Pharmacology, vol. 11, no. 2, pp. 71–81, 2026, doi: 10.18231/j.ijcaap.18440.1784180812.
BibTeX
@article{londhe2026pharmacogenomics,
title = {{Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response}},
author = {Londhe, Gauri Vijay and Phade, Swapnil and Khuspe, Kishori Pankaj},
journal = {IP International Journal of Comprehensive and Advanced Pharmacology},
year = {2026},
volume = {11},
number = {2},
pages = {71--81},
doi = {10.18231/j.ijcaap.18440.1784180812},
url = {https://doi.org/10.18231/j.ijcaap.18440.1784180812}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- pharmacogenetics
- personalized medicine
- genetic determinants of drug response
- drug-metabolizing enzymes
- cytochrome P450
- drug transporters
- clinical implementation
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Londhe, G. V., Phade, S., & Khuspe, K. P. (2026). Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response. IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at IP International Journal of Comprehensive and Advanced Pharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Gauri Vijay Londhe, Swapnil Phade, Kishori Pankaj Khuspe.
What is the DOI of this paper?
10.18231/j.ijcaap.18440.1784180812, permanently at https://doi.org/10.18231/j.ijcaap.18440.1784180812. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.